Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

FULCFULC
10 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in FULCRUM THERAPEUTICS INC

Qube Research & Technologies Ltd holds 1.7M shares of FULC (FULCRUM THERAPEUTICS INC), worth $6.4M as of 2026-Q2. The position was increased (+79.4% shares). FULC represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$6.4M

Current Shares

1.7M

Total Value Change

+$6.2M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+79.4%
$6.4M0.0%$3.66
42
2026-Q1
Increased
974,739
+148.3%
$7.5M0.0%$7.87
44
2025-Q4
New
392,489
-
$4.4M0.0%$11.34
37
2024-Q3
Exited
0
-100.0%
$00.0%$3.77
0
2024-Q2
Decreased
553,307
-23.5%
$3.4M0.0%$6.20
0
2024-Q1
Increased
723,163
+197.7%
$6.8M0.0%$9.44
44
2023-Q4
Increased
242,908
+1759.1%
$1.6M0.0%$6.75
41
2023-Q3
New
13,066
-
$58,0130.0%$4.44
29
2022-Q3
Exited
0
-100.0%
$00.0%$7.79
0
2022-Q2
New
31,813
-
$156,0000.0%$4.95
31

Other major holders of FULC: RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used